• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[特应性皮炎的全身治疗]

[Systemic therapy of atopic dermatitis].

作者信息

Heratizadeh A, Breuer K, Kapp A, Werfel T

机构信息

Klinik und Poliklinik für Dermatologie und Venerologie der Medizinischen Hochschule Hannover, Hannover.

出版信息

Hautarzt. 2003 Oct;54(10):937-45. doi: 10.1007/s00105-003-0605-3.

DOI:10.1007/s00105-003-0605-3
PMID:14513240
Abstract

The optimal treatment of atopic dermatitis requires regular medical supervision. The course of this chronic skin disease is influenced by multiple triggers which are relevant for the treatment. The mainstays of topical therapy include regular use of emollients coupled with antimicrobial substances, corticosteroids and immune modulators as required. Ultraviolet radiation and immunosuppressive regimens represent further options for the treatment of severe exacerbations and may lead to long term improvement. Data from experimental studies provide insight into possible future treatment methods.

摘要

特应性皮炎的最佳治疗需要定期的医学监测。这种慢性皮肤病的病程受到多种与治疗相关的触发因素的影响。局部治疗的主要方法包括定期使用润肤剂,并根据需要联合使用抗菌物质、皮质类固醇和免疫调节剂。紫外线照射和免疫抑制方案是治疗严重病情加重的其他选择,可能会带来长期改善。实验研究的数据为未来可能的治疗方法提供了见解。

相似文献

1
[Systemic therapy of atopic dermatitis].[特应性皮炎的全身治疗]
Hautarzt. 2003 Oct;54(10):937-45. doi: 10.1007/s00105-003-0605-3.
2
Adjunctive Management of Itch in Atopic Dermatitis.特应性皮炎瘙痒的辅助治疗
Dermatol Clin. 2017 Jul;35(3):373-394. doi: 10.1016/j.det.2017.02.011. Epub 2017 May 6.
3
Management of severe atopic dermatitis in children.儿童重度特应性皮炎的管理
J Drugs Dermatol. 2012 Oct;11(10):1158-65.
4
Long-Term Treatment of Atopic Dermatitis.特应性皮炎的长期治疗
Dermatol Clin. 2017 Jul;35(3):335-349. doi: 10.1016/j.det.2017.02.007. Epub 2017 May 6.
5
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.儿童特应性皮炎的全身治疗:初级保健医生综述
Pediatr Ann. 2009 Jul;38(7):380-7. doi: 10.3928/00904481-20090622-08.
6
Non-topical management of recalcitrant paediatric atopic dermatitis.顽固性小儿特应性皮炎的非局部治疗
Arch Dis Child. 2017 Jul;102(7):681-686. doi: 10.1136/archdischild-2016-312106. Epub 2017 Feb 16.
7
[Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].[特应性皮炎患者的诊断、预防和治疗指南。国家皮肤科、性病学和过敏学专家工作组立场文件]
Pol Merkur Lekarski. 2004;17 Suppl 3:3-15.
8
[Therapy of atopic eczema with calcineurin inhibitors].[用钙调神经磷酸酶抑制剂治疗特应性皮炎]
J Dtsch Dermatol Ges. 2005 May;3(5):385-91.
9
[Not Available].[无可用内容]。
Ann Dermatol Venereol. 2019 Dec;146(12S3):12S85-12S95. doi: 10.1016/S0151-9638(20)30018-1.
10
Systemic therapy of atopic dermatitis in children and adults.儿童和成人特应性皮炎的全身治疗
Curr Probl Dermatol. 2011;41:156-164. doi: 10.1159/000323309. Epub 2011 May 12.

引用本文的文献

1
[Local antibiotics or antiseptics in combination with glucocorticoids].
Hautarzt. 2016 Oct;67(10):850-852. doi: 10.1007/s00105-016-3864-5.
2
[Antimicrobially effective compounded medications. Clinical value and critical comments].
Hautarzt. 2005 Aug;56(8):752-8. doi: 10.1007/s00105-005-0974-x.

本文引用的文献

1
[Atopic eczema. Spectrum of provocation factors and possibilities for their effective reduction and elimination].[特应性皮炎。激发因素谱及其有效减少和消除的可能性]
Hautarzt. 2003 Oct;54(10):914-24. doi: 10.1007/s00105-003-0557-7.
2
[Practice experience with topical calcineurin inhibitors].[外用钙调神经磷酸酶抑制剂的实践经验]
Hautarzt. 2003 May;54(5):432-9. doi: 10.1007/s00105-003-0527-0. Epub 2003 Apr 1.
3
[The impact of food allergy in patients with atopic dermatitis].[食物过敏对特应性皮炎患者的影响]
Hautarzt. 2003 Feb;54(2):121-9. doi: 10.1007/s00105-002-0476-z.
4
[Topical corticosteroids versus topical inhibitors of calcineurin].[外用糖皮质激素与外用钙调神经磷酸酶抑制剂]
Hautarzt. 2003 Apr;54(4):338-41. doi: 10.1007/s00105-003-0488-3. Epub 2003 Feb 28.
5
Effect of probiotic Lactobacillus strains in children with atopic dermatitis.益生菌乳酸杆菌菌株对特应性皮炎患儿的影响。
J Allergy Clin Immunol. 2003 Feb;111(2):389-95. doi: 10.1067/mai.2003.389.
6
Randomized, double-blind, placebo-controlled trial of autologous blood therapy for atopic dermatitis.自体血疗法治疗特应性皮炎的随机、双盲、安慰剂对照试验。
Br J Dermatol. 2003 Feb;148(2):307-13. doi: 10.1046/j.1365-2133.2003.04921.x.
7
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis.外用糖皮质激素在特应性皮炎日常管理中的临床剂量及不良反应
Br J Dermatol. 2003 Jan;148(1):128-33. doi: 10.1046/j.1365-2133.2003.04934.x.
8
[Increase in rate of resistance to fusidic acid among Staphylococcus aureus isolates from patients admitted with atopic dermatitis].[来自特应性皮炎住院患者的金黄色葡萄球菌分离株对夫西地酸耐药率的增加]
Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2100-1.
9
Molecular basis of the alteration in skin collagen metabolism in response to in vivo dexamethasone treatment: effects on the synthesis of collagen type I and III, collagenase, and tissue inhibitors of metalloproteinases.体内地塞米松治疗后皮肤胶原代谢改变的分子基础:对Ⅰ型和Ⅲ型胶原、胶原酶及金属蛋白酶组织抑制剂合成的影响
Br J Dermatol. 2002 Nov;147(5):859-68. doi: 10.1046/j.1365-2133.2002.04949.x.
10
[Triclosan, a topical dermatologic agent. In vitro- and in vivo studies on the effectiveness of a new preparation in the New German Formulary].
Hautarzt. 2002 Nov;53(11):724-9. doi: 10.1007/s00105-002-0416-y.